HUTCHMED DRC Operating Cycle Over Time
| HCM Stock | USD 15.00 0.25 1.64% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out HUTCHMED DRC Performance and HUTCHMED DRC Correlation. Will Pharmaceuticals sector continue expanding? Could HUTCHMED diversify its offerings? Factors like these will boost the valuation of HUTCHMED DRC. Market participants price HUTCHMED higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every HUTCHMED DRC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 16.333 | Earnings Share 2.65 | Revenue Per Share | Quarterly Revenue Growth (0.09) | Return On Assets |
Understanding HUTCHMED DRC requires distinguishing between market price and book value, where the latter reflects HUTCHMED's accounting equity. The concept of intrinsic value—what HUTCHMED DRC's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push HUTCHMED DRC's price substantially above or below its fundamental value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, HUTCHMED DRC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Cycle Analysis
Compare HUTCHMED DRC and related stocks such as Bausch Health Companies, Perrigo Company, and Ideaya Biosciences Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BHC | 95.3604 | 263 | 313 | 326 | 250 | 281 | 245 | 239 | 226 | 250 | 249 | 228 | 249 | 304 | 290 | 261 | 198 |
| PRGO | 201 | 201 | 201 | 201 | 201 | 171 | 171 | 183 | 193 | 262 | 202 | 194 | 197 | 198 | 193 | 174 | 142 |
| IDYA | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 35.0653 | 14.4088 | 1.5121 | 0.2809 | 0.1564 | 0.18 | 0.17 |
| SUPN | 7.1 M | 166 | 166 | 2.5 K | 904 | 611 | 582 | 470 | 702 | 665 | 435 | 512 | 474 | 424 | 333 | 383 | 364 |
| CPRX | 100 | 1.0264 | 1.0264 | 1.0264 | 1.0264 | 1.0264 | 1.0264 | 1.0264 | 1.0264 | 85.9859 | 118 | 149 | 90.6101 | 159 | 152 | 137 | 85.55 |
| SRRK | 445 | 445 | 445 | 445 | 445 | 445 | 445 | 445 | 445 | 445 | 30.0749 | 30.0749 | 30.0749 | 30.0749 | 30.0749 | 34.59 | 32.86 |
| ADPT | 165 | 165 | 165 | 165 | 165 | 165 | 165 | 165 | 177 | 203 | 265 | 184 | 170 | 151 | 128 | 147 | 198 |
| MLYS | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| CDTX | (176) | (176) | (176) | (176) | (176) | (176) | (176) | (176) | 0.1745 | 0.1745 | 338 | 26.4868 | 33.0351 | 315 | 485 | 436 | 458 |
| KNSA | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 185 | 378 | 230 | 194 | 223 | 271 |
HUTCHMED DRC and related stocks such as Bausch Health Companies, Perrigo Company, and Ideaya Biosciences Operating Cycle description
My Equities
My Current Equities and Potential Positions
| HUTCHMED DRC | HCM |
| Classification | Cancer Fighters |
| Business Address | Cheung Kong Center, |
| Exchange | NASDAQ Exchange |
USD 15.0
Check out HUTCHMED DRC Performance and HUTCHMED DRC Correlation. To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
HUTCHMED DRC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.